Delayed Diagnosis of Squamous Cell Carcinoma of the Scrotum in a Patient with Behçet's Disease

Received July 27, 2011, Revised January 26, 2012, Accepted for publication February 1, 2012 Corresponding author: Enver Turan, M.D., Department of Dermatology, Ministry of Health Hospital, Gültepe mah. Eflatun cad. No: 1 Batman/Turkey. Tel: +9005053323929 Fax: +900488 221 30 68, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 2. Mashiah J, Brenner S. Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod. Clin Exp Dermatol 2008;33:74-76. 3. Dahl MV. Imiquimod: a cytokine inducer. J Am Acad Dermatol 2002;47(4 Suppl):S205-208. 4. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002;15:87-92. 5. Al-Dujaili Z, Hsu S. Imiquimod-induced vitiligo. Dermatol Online J 2007;13:10.